Mural Oncology Statistics

Total Valuation

Mural Oncology has a market cap or net worth of $58.05 million. The enterprise value is -$162.11 million.

Market Cap	58.05M
Enterprise Value	-162.11M

Important Dates

The next estimated earnings date is Thursday, August 15, 2024, before market open.

Earnings Date	Aug 15, 2024
Ex-Dividend Date	n/a

Share Statistics

Mural Oncology has 16.92 million shares outstanding. The number of shares has increased by 0.62% in one year.

Shares Outstanding	16.92M
Shares Change (YoY)	+0.62%
Shares Change (QoQ)	+0.62%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.25
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.27, with a Debt / Equity ratio of 0.06.

Current Ratio	11.27
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	117
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.39
200-Day Moving Average	n/a
Relative Strength Index (RSI)	59.80
Average Volume (20 Days)	339,140

Short Selling Information

The latest short interest is 1.11 million, so 6.55% of the outstanding shares have been sold short.

Short Interest	1.11M
Short Previous Month	1.36M
Short % of Shares Out	6.55%
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $233.64 million in cash and $13.49 million in debt, giving a net cash position of $220.16 million or $13.01 per share.

Cash & Cash Equivalents	233.64M
Total Debt	13.49M
Net Cash	220.16M
Net Cash Per Share	$13.01
Equity (Book Value)	234.93M
Book Value Per Share	13.88
Working Capital	218.18M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mural Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.62%
Shareholder Yield	-0.62%
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

The average price target for Mural Oncology is $14.00, which is 308.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	308.16%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a